• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英夫利昔单抗用于肝移植后溃疡性结肠炎的治疗

Infliximab for ulcerative colitis following liver transplantation.

作者信息

Lal Simon, Steinhart A Hillary

机构信息

Department of Gastroenterology, University Hospitals, Aintree, Liverpool, UK.

出版信息

Eur J Gastroenterol Hepatol. 2007 Mar;19(3):277-80. doi: 10.1097/MEG.0b013e3280116ccc.

DOI:10.1097/MEG.0b013e3280116ccc
PMID:17301656
Abstract

Primary sclerosing cholangitis is a chronic cholestatic disease with a progressive course, often culminating in hepatic transplantation. When associated with primary sclerosing cholangitis, ulcerative colitis commonly follows a mild course before, but a more progressive course following liver transplantation, with a significant proportion of patients becoming steroid dependent and/or requiring colectomy. We report the first case demonstrating the efficacy and safety of infliximab therapy for ulcerative colitis following hepatic transplantation.

摘要

原发性硬化性胆管炎是一种病程呈进行性发展的慢性胆汁淤积性疾病,常最终需要进行肝移植。当与原发性硬化性胆管炎相关时,溃疡性结肠炎在肝移植前通常病程较轻,但在肝移植后病程更为进展,相当一部分患者会出现激素依赖和/或需要行结肠切除术。我们报告首例证明英夫利昔单抗治疗肝移植后溃疡性结肠炎有效性和安全性的病例。

相似文献

1
Infliximab for ulcerative colitis following liver transplantation.英夫利昔单抗用于肝移植后溃疡性结肠炎的治疗
Eur J Gastroenterol Hepatol. 2007 Mar;19(3):277-80. doi: 10.1097/MEG.0b013e3280116ccc.
2
Infliximab for refractory ulcerative colitis.英夫利昔单抗治疗难治性溃疡性结肠炎。
Am J Gastroenterol. 2001 Aug;96(8):2373-81. doi: 10.1111/j.1572-0241.2001.04039.x.
3
Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.临床试验:溃疡性结肠炎挽救治疗后的结肠切除术-瑞典丹麦对照英夫利昔单抗研究的 3 年随访。
Aliment Pharmacol Ther. 2010 Oct;32(8):984-9. doi: 10.1111/j.1365-2036.2010.04435.x. Epub 2010 Aug 18.
4
[Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].英夫利昔单抗用于中度至重度激素依赖型或激素抵抗型溃疡性结肠炎
Recenti Prog Med. 2007 Nov;98(11):560-4.
5
Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.溃疡性结肠炎患者接受英夫利昔单抗治疗后的黏膜愈合的超微结构证据。
J Gastrointestin Liver Dis. 2010 Jun;19(2):147-53.
6
Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.英夫利昔单抗治疗溃疡性结肠炎:2000年至2006年牛津地区的治疗结果
Aliment Pharmacol Ther. 2007 May 1;25(9):1055-60. doi: 10.1111/j.1365-2036.2007.03300.x.
7
A review of infliximab use in ulcerative colitis.英夫利昔单抗在溃疡性结肠炎中的应用综述。
Clin Ther. 2008 Feb;30(2):223-30. doi: 10.1016/j.clinthera.2008.02.014.
8
The use of the anti-tumour necrosis factor monoclonal antibody--infliximab--to treat ulcerative colitis: implications and trends beyond the available data.
Dig Liver Dis. 2004 Jun;36(6):426-31. doi: 10.1016/j.dld.2004.01.021.
9
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.英夫利昔单抗治疗重度溃疡性结肠炎:不同输注方案的短期结果及长期随访
Aliment Pharmacol Ther. 2007 Sep 1;26(5):747-56. doi: 10.1111/j.1365-2036.2007.03415.x.
10
[Primary sclerosing cholangitis--an ulcerative colitis-associated illness with surgical consequences].[原发性硬化性胆管炎——一种与溃疡性结肠炎相关且具有手术后果的疾病]
Chirurg. 1998 Oct;69(10):1028-34.

引用本文的文献

1
Concurrent inflammatory bowel disease and primary sclerosing cholangitis: a review of pre- and post-transplant outcomes and treatment options.炎症性肠病与原发性硬化性胆管炎并存:移植前后结局及治疗选择综述
Gastroenterol Hepatol Bed Bench. 2023;16(3):259-269. doi: 10.22037/ghfbb.v16i2.2589.
2
Incidence and Impacts of Inflammatory Bowel Diseases among Kidney Transplant Recipients: A Meta-Analysis.肾移植受者中炎症性肠病的发病率及影响:一项荟萃分析
Med Sci (Basel). 2020 Sep 16;8(3):39. doi: 10.3390/medsci8030039.
3
Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
原发性硬化性胆管炎行肝移植术后新发和已确立的炎症性肠病的自然病程。
Inflamm Bowel Dis. 2018 Apr 23;24(5):1074-1081. doi: 10.1093/ibd/izx096.
4
Inflammatory bowel disease in liver transplanted patients.肝移植患者中的炎症性肠病
World J Gastroenterol. 2017 May 14;23(18):3214-3227. doi: 10.3748/wjg.v23.i18.3214.
5
Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes.抗TNFα疗法用于肾移植受者慢性炎症性疾病:临床结局
Medicine (Baltimore). 2016 Oct;95(41):e5108. doi: 10.1097/MD.0000000000005108.
6
Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.炎症性肠病(IBD)患者的实体器官移植:大型单中心队列中移植结局与IBD活动度分析
PLoS One. 2015 Aug 19;10(8):e0135807. doi: 10.1371/journal.pone.0135807. eCollection 2015.
7
Management of ulcerative colitis pre- and post-liver transplant for primary sclerosing cholangitis: two case reports and review of literature.原发性硬化性胆管炎肝移植前后溃疡性结肠炎的管理:两例病例报告及文献综述
Int J Colorectal Dis. 2014 Nov;29(11):1313-20. doi: 10.1007/s00384-014-1945-4. Epub 2014 Jul 4.
8
Clinical management of inflammatory bowel disease in the organ recipient.器官移植受者炎症性肠病的临床管理
World J Gastroenterol. 2014 Apr 7;20(13):3525-33. doi: 10.3748/wjg.v20.i13.3525.
9
Primary Sclerosing Cholangitis: Current and Future Management Strategies.原发性硬化性胆管炎:当前及未来的管理策略
Curr Hepat Rep. 2013 Mar 1;12(1):28-36. doi: 10.1007/s11901-012-0155-1.
10
Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease.成人肝移植受者斯蒂尔病相关噬血细胞综合征。
Hepatol Int. 2010 Oct 24;5(1):597-602. doi: 10.1007/s12072-010-9218-y.